MedTrace Logo

Chronic Effects of Euphytose® on Psychological and Physiological Measures of Stress

NCT03909906 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-03-03

No results posted yet for this study

Summary

The aim of this study is to assess the chronic effects (14 days) of Euphytose® on psychological state, physiological stress responses and any resulting changes in gut microflora communities as compared to placebo.

Conditions

  • Mood

Interventions

DRUG

Euphytose®

(50mg Valeriana officinalis L., 40mg Passiflora incarnate L., 10mg Crataegus sp., 10mg Ballota nigra L.)

DRUG

Placebo Oral Tablet

Placebo comparator

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Northumbria University

    lead OTHER

Principal Investigators

  • Philippa Jackson, Dr · Study Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-03
Primary Completion
2019-12-18
Completion
2019-12-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03909906 on ClinicalTrials.gov